Analytical tools for characterizing biopharmaceuticals

被引：0
|
作者：
Laffman-Johnson, Elise
机构：
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2012年 / 92卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：406 / 406
页数：1
相关论文
共 50 条
  • [21] Role of analytical ultracentrifugation in assessing the aggregation of protein biopharmaceuticals
    Berkowitz, Steven A.
    AAPS JOURNAL, 2006, 8 (03): : E590 - E605
  • [22] Valuation of biopharmaceuticals - Calculating value of research tools and platform technology
    Khoury, S
    Lukeman, DS
    GENETIC ENGINEERING NEWS, 2002, 22 (04): : 6 - +
  • [23] The role of process simulation and scheduling tools in the development and manufacturing of biopharmaceuticals
    Petrides, DP
    Siletti, CA
    PROCEEDINGS OF THE 2004 WINTER SIMULATION CONFERENCE, VOLS 1 AND 2, 2004, : 2046 - 2051
  • [24] Potential of hydrophilic interaction chromatography for the analytical characterization of protein biopharmaceuticals
    Periat, Aurelie
    Fekete, Szabolcs
    Cusumano, Alessandra
    Veuthey, Jean-Luc
    Beck, Alain
    Lauber, Matthew
    Guillarme, Davy
    JOURNAL OF CHROMATOGRAPHY A, 2016, 1448 : 81 - 92
  • [25] Validating analytical methods for biopharmaceuticals Part 2 Formal validations
    Krause, SO
    BIOPHARM INTERNATIONAL, 2004, 17 (11) : 46 - +
  • [26] Current Trends in Analytical Technologies Which Promote the Development of Biopharmaceuticals
    Ishii-Watabe, Akiko
    Uchiyama, Susumu
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2018, 138 (12): : 1473 - 1474
  • [27] Validating analytical methods for biopharmaceuticals, Part 1: Development and optimization
    Krause, SO
    BIOPHARM INTERNATIONAL-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 2004, 17 (10): : 52 - +
  • [28] Improved analytical methods for the detection and quantification of neutralizing antibodies to biopharmaceuticals
    Tovey, Michael G.
    Lallemand, Christophe
    BIOANALYSIS, 2012, 4 (17) : 2179 - 2190
  • [29] Role of process simulation and scheduling tools in the development and commercialization of biopharmaceuticals.
    Petrides, D
    Siletti, C
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U237 - U237
  • [30] Emerging mass spectrometry-based tools to characterize stability of biopharmaceuticals
    Kaltashov, Igor A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
12345